BackMera Pharmaceuticals Overview
Mera Pharmaceuticals, Inc.

Mera Pharmaceuticals Return on Equity

Mera Pharmaceuticals (MRPI) has a ROE of 21.71%, above the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

21.71%

Return on Equity

21.71%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Mera Pharmaceuticals (MRPI) FAQ

Mera Pharmaceuticals (MRPI) currently reports a ROE of 21.71%. That is above the Healthcare sector average of 13.1%. Use the charts on this page to explore Mera Pharmaceuticals's ROE history and peer comparisons.

Mera Pharmaceuticals's ROE of 21.71% is higher than the Healthcare sector average of 13.1%. That is roughly 65.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Mera Pharmaceuticals's current 21.71% should be judged against Healthcare norms (sector average: 13.1%) and against MRPI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 21.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.1%. From there, open related valuation or income-statement pages for Mera Pharmaceuticals, and consider following MRPI for alerts when major investors trade the stock.

Mera Pharmaceuticals is classified in the Healthcare sector. On ROE, it currently shows 21.71% versus a sector average near 13.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRPI with unrelated industries.